Pub Date : 2026-01-19DOI: 10.1016/j.jpeds.2026.114997
Valerie J Flaherman, Harrison T Reeder, Susanne P Martin-Herz, Richard Gallagher, Alison K Cohen, Heather-Elizabeth Brown, Rebecca G Clifton, Nicole Fischbein, Andrea S Foulkes, Vanessa L Jacoby, Nita Jain, Carmen J Beamon, Mert Ozan Bahtiyar, Ann Chang, Maged M Costantine, Angelique Cruz Irving, Kelly S Gibson, M Camille Hoffman, Matthew K Hoffman, Brenna L Hughes, Stuart D Katz, Victoria Laleau, Hector Mendez-Figueroa, Jonathan Monteiro, Megumi J Okumura, Luis D Pacheco, Kristy T S Palomares, Samuel Parry, Beth A Plunkett, Uma M Reddy, Dwight J Rouse, George R Saade, Grecio J Sandoval, Hyagriv N Simhan, Daniel W Skupski, Amber Sowles, John M Thorp, Alan T N Tita, Steven J Weiner, Samantha Wiegand, Lynn M Yee, Rachel S Gross, Torri D Metz
Objective: To assess associations between exposure to intrauterine SARS-CoV-2 and subsequent child neurodevelopment in a large, diverse cohort with confirmation of maternal SARS-CoV-2 status.
Study design: The Researching COVID to Enhance Recovery (RECOVER) Pregnancy Cohort enrolled adults with and without SARS-CoV-2 during pregnancy and their offspring born January 2020 through December 2023 at 23 sites across the US. Neurodevelopment was assessed at 12 months with the Ages & Stages Questionnaire, 3rd edition (ASQ-3) and at 18 months with the ASQ Social-Emotional (ASQ-SE) and the Modified Checklist for Autism in Toddlers-Revised (M-CHAT-R). We compared exposed and unexposed infants' ASQ-3 total and subdomain scores, ASQ-SE and M-CHAT-R scores, and proportions meeting published referral thresholds, using multivariable linear and logistic regression.
Results: Among 1179 participants enrolled, 1008 (85.5%) had exposure, with 806 (80.0%) exposed during Omicron predominance. Of those with known timing, 349 (41.4%) and 295 (35.0%) were exposed in the second and third trimesters of pregnancy, respectively. Exposure was not associated with differences in the ASQ-3 (adjusted difference -0.61, 95% CI -10.03 to 8.81) or ASQ-3 subdomains at 12 months, ASQ-SE at 18 months (adjusted difference 0.19, 95% CI -4.02 to 4.41), or M-CHAT-R scores. Findings were similar for proportions meeting referral thresholds and when stratified by variant or by trimester.
Conclusions: In this multicenter cohort largely exposed since Omicron and in second or third trimester, intrauterine SARS-CoV-2 exposure was not associated with neurodevelopmental screening outcomes through 18 months of age. Further assessments of the impact of intrauterine SARS-CoV-2 on neurodevelopment beyond 18 months of age are needed.
{"title":"Intrauterine SARS-CoV-2 Exposure and Infant Neurodevelopment through 18 Months of Age: Findings from the Researching COVID to Enhance Recovery (RECOVER) Pregnancy Study.","authors":"Valerie J Flaherman, Harrison T Reeder, Susanne P Martin-Herz, Richard Gallagher, Alison K Cohen, Heather-Elizabeth Brown, Rebecca G Clifton, Nicole Fischbein, Andrea S Foulkes, Vanessa L Jacoby, Nita Jain, Carmen J Beamon, Mert Ozan Bahtiyar, Ann Chang, Maged M Costantine, Angelique Cruz Irving, Kelly S Gibson, M Camille Hoffman, Matthew K Hoffman, Brenna L Hughes, Stuart D Katz, Victoria Laleau, Hector Mendez-Figueroa, Jonathan Monteiro, Megumi J Okumura, Luis D Pacheco, Kristy T S Palomares, Samuel Parry, Beth A Plunkett, Uma M Reddy, Dwight J Rouse, George R Saade, Grecio J Sandoval, Hyagriv N Simhan, Daniel W Skupski, Amber Sowles, John M Thorp, Alan T N Tita, Steven J Weiner, Samantha Wiegand, Lynn M Yee, Rachel S Gross, Torri D Metz","doi":"10.1016/j.jpeds.2026.114997","DOIUrl":"10.1016/j.jpeds.2026.114997","url":null,"abstract":"<p><strong>Objective: </strong>To assess associations between exposure to intrauterine SARS-CoV-2 and subsequent child neurodevelopment in a large, diverse cohort with confirmation of maternal SARS-CoV-2 status.</p><p><strong>Study design: </strong>The Researching COVID to Enhance Recovery (RECOVER) Pregnancy Cohort enrolled adults with and without SARS-CoV-2 during pregnancy and their offspring born January 2020 through December 2023 at 23 sites across the US. Neurodevelopment was assessed at 12 months with the Ages & Stages Questionnaire, 3rd edition (ASQ-3) and at 18 months with the ASQ Social-Emotional (ASQ-SE) and the Modified Checklist for Autism in Toddlers-Revised (M-CHAT-R). We compared exposed and unexposed infants' ASQ-3 total and subdomain scores, ASQ-SE and M-CHAT-R scores, and proportions meeting published referral thresholds, using multivariable linear and logistic regression.</p><p><strong>Results: </strong>Among 1179 participants enrolled, 1008 (85.5%) had exposure, with 806 (80.0%) exposed during Omicron predominance. Of those with known timing, 349 (41.4%) and 295 (35.0%) were exposed in the second and third trimesters of pregnancy, respectively. Exposure was not associated with differences in the ASQ-3 (adjusted difference -0.61, 95% CI -10.03 to 8.81) or ASQ-3 subdomains at 12 months, ASQ-SE at 18 months (adjusted difference 0.19, 95% CI -4.02 to 4.41), or M-CHAT-R scores. Findings were similar for proportions meeting referral thresholds and when stratified by variant or by trimester.</p><p><strong>Conclusions: </strong>In this multicenter cohort largely exposed since Omicron and in second or third trimester, intrauterine SARS-CoV-2 exposure was not associated with neurodevelopmental screening outcomes through 18 months of age. Further assessments of the impact of intrauterine SARS-CoV-2 on neurodevelopment beyond 18 months of age are needed.</p>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":" ","pages":"114997"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1016/j.jpeds.2026.114998
Jip A Spekman, Sophie G Groene, Monique C Haak, Lisette M Harteveld, Francisca P de Klerk-Voll, Eric de Groot, Jeanine M M van Klink, Enrico Lopriore, Arno A W Roest
Objective: To investigate the effect of fetal growth restriction (FGR) on cardiovascular structure and function in childhood in a growth-discordant identical twin model, thereby adjusting naturally for genetic, obstetric, and environmental confounding factors.
Study design: This study is part of the LEMON cohort study of growth-discordant identical twins born at the Leiden University Medical Center, The Netherlands. Echocardiography was prospectively performed in 42 twin pairs aged between 5 and 17 years. Growth discordance was defined as a birth weight discordance ≥20%. Outcome measures were compared between the smaller and larger twin and included structural measures (left ventricular [LV] dimensions and carotid intima-media thickness) as well as functional measures (LV systolic and diastolic function using Doppler and LV strain imaging, and aortic pulsed wave velocity).
Results: Median gestational age at birth was 34.1 weeks (IQR 31.6-36.0) with median birth weights of 1471 g (IQR 1114-1876) and 2025 g (IQR 1623-2705) for the smaller and larger twin, respectively. Median age at echocardiography was 11 years (IQR 9-14). Smaller twins presented with significantly lower LV global longitudinal strain (-19.6% vs -20.7%), and higher mitral peak E and A velocities, and mitral E/e' ratio compared with larger co-twins. No within-pair differences were found regarding structural cardiovascular parameters, carotid intima-media thickness and aortic pulsed wave velocity.
Conclusions: In a growth-discordant identical twin model, FGR is associated with subclinical changes in myocardial structure and systolic and diastolic LV function in the smaller growth-restricted twin compared with the larger appropriately-grown co-twin. This finding indicates that adverse cardiovascular remodeling after FGR persists into childhood, potentially influencing long-term risk of cardiovascular disease.
Trial registration: International Clinical Trial Registry Platform ID NL9833 (https://trialsearch.who.int/).
目的:探讨胎儿生长受限(FGR)对生长不协调同卵双生儿模型儿童期心血管结构和功能的影响,从而对遗传、产科和环境混杂因素进行自然调整。研究设计:本研究是LEMON队列研究的一部分,研究对象是荷兰莱顿大学医学中心出生的生长不协调的同卵双胞胎。前瞻性地对42对5 - 17岁的双胞胎进行超声心动图检查。生长不一致定义为出生体重不一致≥20%。比较小双胞胎和大双胞胎的预后指标,包括结构指标(左心室(LV)尺寸和颈动脉内膜-中膜厚度[cIMT])以及功能指标(采用多普勒和左室应变成像的左室收缩和舒张功能,以及主动脉脉冲波速度[aPWV])。结果:出生时中位胎龄为34.1周(IQR 31.6-36.0),中位出生体重分别为1471克(IQR 1114-1876)和2025克(IQR 1623-2705)。超声心动图的中位年龄为11岁(IQR 9-14)。与体型较大的双胞胎相比,体型较小的双胞胎LV整体纵向应变明显较低(-19.6% vs -20.7%),二尖瓣峰值E和A速度以及二尖瓣E/ E′比均较高。在心血管结构参数、cIMT和aPWV方面未发现配对内差异。结论:在生长不协调的同卵双胞胎模型中,与发育正常的同卵双胞胎相比,生长受限的小双胞胎的FGR与心肌结构和左室收缩和舒张功能的亚临床变化有关。这一发现表明,FGR后的不良心血管重塑持续到儿童期,可能影响心血管疾病的长期风险。
{"title":"Long-Term Effects of Fetal Growth Restriction on Cardiovascular Structure and Function: A Cohort Study in Growth-Discordant Identical Twins.","authors":"Jip A Spekman, Sophie G Groene, Monique C Haak, Lisette M Harteveld, Francisca P de Klerk-Voll, Eric de Groot, Jeanine M M van Klink, Enrico Lopriore, Arno A W Roest","doi":"10.1016/j.jpeds.2026.114998","DOIUrl":"10.1016/j.jpeds.2026.114998","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effect of fetal growth restriction (FGR) on cardiovascular structure and function in childhood in a growth-discordant identical twin model, thereby adjusting naturally for genetic, obstetric, and environmental confounding factors.</p><p><strong>Study design: </strong>This study is part of the LEMON cohort study of growth-discordant identical twins born at the Leiden University Medical Center, The Netherlands. Echocardiography was prospectively performed in 42 twin pairs aged between 5 and 17 years. Growth discordance was defined as a birth weight discordance ≥20%. Outcome measures were compared between the smaller and larger twin and included structural measures (left ventricular [LV] dimensions and carotid intima-media thickness) as well as functional measures (LV systolic and diastolic function using Doppler and LV strain imaging, and aortic pulsed wave velocity).</p><p><strong>Results: </strong>Median gestational age at birth was 34.1 weeks (IQR 31.6-36.0) with median birth weights of 1471 g (IQR 1114-1876) and 2025 g (IQR 1623-2705) for the smaller and larger twin, respectively. Median age at echocardiography was 11 years (IQR 9-14). Smaller twins presented with significantly lower LV global longitudinal strain (-19.6% vs -20.7%), and higher mitral peak E and A velocities, and mitral E/e' ratio compared with larger co-twins. No within-pair differences were found regarding structural cardiovascular parameters, carotid intima-media thickness and aortic pulsed wave velocity.</p><p><strong>Conclusions: </strong>In a growth-discordant identical twin model, FGR is associated with subclinical changes in myocardial structure and systolic and diastolic LV function in the smaller growth-restricted twin compared with the larger appropriately-grown co-twin. This finding indicates that adverse cardiovascular remodeling after FGR persists into childhood, potentially influencing long-term risk of cardiovascular disease.</p><p><strong>Trial registration: </strong>International Clinical Trial Registry Platform ID NL9833 (https://trialsearch.who.int/).</p>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":" ","pages":"114998"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1016/j.jpeds.2026.115000
Patrick D Evers, Austin F Menezes, Brian Scottoline, Cindy T McEvoy, Paul J Critser, Brian K Jordan
Objective: To quantify the impact of nonhemodynamically significant patent ductus arteriosus (non-hsPDA) on pulmonary function in neonates.
Study design: We analyzed a retrospective cohort of very low birthweight (<1500 g) infants born <32 weeks' gestation admitted to a single tertiary neonatal intensive care unit between 2019 and 2023 who underwent both echocardiography and pulmonary function testing at approximately 34 weeks postmenstrual age. Infants with ventricular or atrial septal defects were excluded. Passive respiratory compliance (Crs) was compared among infants with hsPDA, non-hsPDA, and age-matched controls without PDA using one-sided t-tests and ANOVA, with multivariable regression controlling for birth weight and length.
Results: Twenty-four infants were analyzed (8 hsPDA, 8 non-hsPDA, 8 controls). Mean Crs was significantly reduced in both hsPDA (0.83 ± 0.34 mL/cmH2O/kg) and non-hsPDA (0.92 ± 0.21) groups compared with controls (1.23 ± 0.34; P < .05). The presence of PDA demonstrated a stepwise inverse relationship with Crs that persisted after adjustment for covariates.
Conclusions: Even non-hsPDAs are associated with measurable reductions in pulmonary compliance among preterm infants. These findings suggest that current binary classifications of PDA significance may underestimate pulmonary impact and support re-evaluation of management thresholds for "non-significant" shunts.
{"title":"Impact of Nonhemodynamically Significant Patent Ductus Arteriosus on Pulmonary Function in Premature Neonates.","authors":"Patrick D Evers, Austin F Menezes, Brian Scottoline, Cindy T McEvoy, Paul J Critser, Brian K Jordan","doi":"10.1016/j.jpeds.2026.115000","DOIUrl":"10.1016/j.jpeds.2026.115000","url":null,"abstract":"<p><strong>Objective: </strong>To quantify the impact of nonhemodynamically significant patent ductus arteriosus (non-hsPDA) on pulmonary function in neonates.</p><p><strong>Study design: </strong>We analyzed a retrospective cohort of very low birthweight (<1500 g) infants born <32 weeks' gestation admitted to a single tertiary neonatal intensive care unit between 2019 and 2023 who underwent both echocardiography and pulmonary function testing at approximately 34 weeks postmenstrual age. Infants with ventricular or atrial septal defects were excluded. Passive respiratory compliance (Crs) was compared among infants with hsPDA, non-hsPDA, and age-matched controls without PDA using one-sided t-tests and ANOVA, with multivariable regression controlling for birth weight and length.</p><p><strong>Results: </strong>Twenty-four infants were analyzed (8 hsPDA, 8 non-hsPDA, 8 controls). Mean Crs was significantly reduced in both hsPDA (0.83 ± 0.34 mL/cmH<sub>2</sub>O/kg) and non-hsPDA (0.92 ± 0.21) groups compared with controls (1.23 ± 0.34; P < .05). The presence of PDA demonstrated a stepwise inverse relationship with Crs that persisted after adjustment for covariates.</p><p><strong>Conclusions: </strong>Even non-hsPDAs are associated with measurable reductions in pulmonary compliance among preterm infants. These findings suggest that current binary classifications of PDA significance may underestimate pulmonary impact and support re-evaluation of management thresholds for \"non-significant\" shunts.</p>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":" ","pages":"115000"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12860412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1016/j.jpeds.2026.114996
Yuqing Lei MS , Ting Zhou MD, PhD , Bingyu Zhang MS , Dazheng Zhang PhD , Huilin Tang PhD , Jiajie Chen PhD , Qiong Wu PhD , Lu Li BS , L. Charles Bailey MD, PhD , Michael J. Becich MD, PhD , Saul Blecker MD, MHS , Dimitri A. Christakis MD, MPH , Daniel Fort PhD, MPH , Sharon J. Herring MD, MPH , Wenke Hwang PhD , Amrik Singh Khalsa MD, MSc, FAAP, FACP , Susan Kim MD, MMSc , David M. Liebovitz MD , Abu Saleh Mohammad Mosa PhD, MS, FAMIA , Suchitra Rao MBBS, MSCS , Yong Chen PhD
Objective
To evaluate the risks of incident dyslipidemia and abnormal body mass index (BMI) during the 28-179-day postacute phase after documented SARS-CoV-2 infection in a large pediatric sample.
Study design
A retrospective cohort study using the Researching COVID to Enhance Recovery pediatric electronic health record datasets from 25 US children's hospitals and health institutions, from March 2020 to September 2023. This study included 384 289 COVID-19-positive patients aged 0-21 years for dyslipidemia analyses and 285 559 aged 2-21 years for BMI analyses, each with at least 6 months of follow-up. COVID-19-negative controls included 1 080 413 and 817 315 patients, respectively. SARS-CoV-2 infection was defined by a positive polymerase chain reaction, antigen, or serologic test; a clinical diagnosis of COVID-19; or a documented diagnosis of post-acute sequelae of SARS-CoV-2. Incident dyslipidemia and abnormal BMI were identified using age-specific laboratory or anthropometric thresholds. Adjusted relative risks (aRRs) were estimated using propensity-score-stratified modified Poisson regression with multiple sensitivity analyses.
Results
During the postacute phase, the COVID-19-positive cohort had higher rates of new-onset composite dyslipidemia (aRR 1.24; 95% CI 1.18-1.29) and abnormal BMI (aRR 1.15; 95% CI, 1.12-1.18). Results were robust to sensitivity and stratified analyses.
Conclusions
Children and adolescents with documented COVID-19 infection were associated with an increased risk of new-onset dyslipidemia and abnormal BMI during the postacute phase, highlighting the need for metabolic monitoring after infection.
目的:评估大量儿童SARS-CoV-2感染后急性期28-179天内发生血脂异常和体重指数(BMI)异常的风险。研究设计:一项回顾性队列研究,使用来自25家美国儿童医院和卫生机构的RECOVER儿童电子健康记录(EHR)数据集,时间为2020年3月至2023年9月。该研究包括384289名年龄在0-21岁的covid -19阳性患者进行血脂异常分析,285559名年龄在2-21岁的患者进行BMI分析,每名患者至少进行6个月的随访。阴性对照分别为1080413例和817315例。SARS-CoV-2感染的定义是聚合酶链反应(PCR)、抗原或血清学检测阳性;1例COVID-19临床诊断;或确诊为SARS-CoV-2急性后后遗症(PASC)。使用特定年龄的实验室或人体测量阈值确定偶发的血脂异常和异常BMI。校正相对危险度(aRRs)采用倾向评分分层修正泊松回归与多敏感性分析进行估计。结果:急性期后,新发复合血脂异常(aRR 1.24, 95% CI 1.18-1.29)和BMI异常(aRR 1.15, 95% CI 1.12-1.18)发生率较高。结果对敏感性和分层分析具有稳健性。结论:记录在案的COVID-19感染儿童和青少年与急性期后新发血脂异常和BMI异常的风险增加相关,突出了感染后代谢监测的必要性。
{"title":"Post-Acute Dyslipidemia and Abnormal Body Mass Index in Children and Adolescents with COVID-19: A Cohort Study from the RECOVER Initiative","authors":"Yuqing Lei MS , Ting Zhou MD, PhD , Bingyu Zhang MS , Dazheng Zhang PhD , Huilin Tang PhD , Jiajie Chen PhD , Qiong Wu PhD , Lu Li BS , L. Charles Bailey MD, PhD , Michael J. Becich MD, PhD , Saul Blecker MD, MHS , Dimitri A. Christakis MD, MPH , Daniel Fort PhD, MPH , Sharon J. Herring MD, MPH , Wenke Hwang PhD , Amrik Singh Khalsa MD, MSc, FAAP, FACP , Susan Kim MD, MMSc , David M. Liebovitz MD , Abu Saleh Mohammad Mosa PhD, MS, FAMIA , Suchitra Rao MBBS, MSCS , Yong Chen PhD","doi":"10.1016/j.jpeds.2026.114996","DOIUrl":"10.1016/j.jpeds.2026.114996","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the risks of incident dyslipidemia and abnormal body mass index (BMI) during the 28-179-day postacute phase after documented SARS-CoV-2 infection in a large pediatric sample.</div></div><div><h3>Study design</h3><div>A retrospective cohort study using the Researching COVID to Enhance Recovery pediatric electronic health record datasets from 25 US children's hospitals and health institutions, from March 2020 to September 2023. This study included 384 289 COVID-19-positive patients aged 0-21 years for dyslipidemia analyses and 285 559 aged 2-21 years for BMI analyses, each with at least 6 months of follow-up. COVID-19-negative controls included 1 080 413 and 817 315 patients, respectively. SARS-CoV-2 infection was defined by a positive polymerase chain reaction, antigen, or serologic test; a clinical diagnosis of COVID-19; or a documented diagnosis of post-acute sequelae of SARS-CoV-2. Incident dyslipidemia and abnormal BMI were identified using age-specific laboratory or anthropometric thresholds. Adjusted relative risks (aRRs) were estimated using propensity-score-stratified modified Poisson regression with multiple sensitivity analyses.</div></div><div><h3>Results</h3><div>During the postacute phase, the COVID-19-positive cohort had higher rates of new-onset composite dyslipidemia (aRR 1.24; 95% CI 1.18-1.29) and abnormal BMI (aRR 1.15; 95% CI, 1.12-1.18). Results were robust to sensitivity and stratified analyses.</div></div><div><h3>Conclusions</h3><div>Children and adolescents with documented COVID-19 infection were associated with an increased risk of new-onset dyslipidemia and abnormal BMI during the postacute phase, highlighting the need for metabolic monitoring after infection.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"291 ","pages":"Article 114996"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1016/j.jpeds.2026.115003
Divya Chhabra, Jingyang Lin, Jinsheng Pan, Irina Prelipcean, Igor Khodak, Colby L Day, Jack Chang, Xing Qiu, Jiebo Luo, Andrew M Dylag
Objective: To build a time-series machine learning (ML) model that improves bronchopulmonary dysplasia (BPD) prediction compared with published online calculators.
Study design: We used a single-center, extremely low gestational age newborn cohort (inborn, birth year 2016-2021, n = 438). The primary outcome was a 5-level class outcome for BPD as defined by the Neonatal Research Network (NRN) in 2019. Flowsheet data were extracted from the electronic medical record. Time-series data were generated from birth onward, with 14 static and 35 dynamic input attributes. Iterative static (regression) and dynamic (ML) modeling was performed, comparing model performance with the NRN BPD calculator at several time points (postnatal day 1, 3, 7, 14, and 28) and ranking feature leverage at each time point.
Results: Of the original cohort, 92 infants met all inclusion criteria (gestational age 25.6 ± 1.4 weeks). Static models performed comparably with the NRN BPD calculator (area under the curve = 0.7460), improving to 0.7978 with forward/backward selection. In contrast, dynamic long short-term memory (LSTM) models outperformed static models at all time points, reaching a peak area under the curve of 0.8400 on postnatal day 28. LSTM models performed best for no BPD and severe disease/death. Principal component analysis revealed that respiratory support, ventilator settings, supplemental oxygen requirements, medications, and prenatal/postnatal growth were major factors driving BPD severity.
Conclusions: LSTM-based ML time-series analysis substantially outperformed static approaches for predicting BPD and death among extremely low gestational age newborns. Integrating ML methods into clinical applications holds promise for enhancing real-time BPD trajectory mapping.
{"title":"Time-Series Machine Learning for Prediction of Bronchopulmonary Dysplasia.","authors":"Divya Chhabra, Jingyang Lin, Jinsheng Pan, Irina Prelipcean, Igor Khodak, Colby L Day, Jack Chang, Xing Qiu, Jiebo Luo, Andrew M Dylag","doi":"10.1016/j.jpeds.2026.115003","DOIUrl":"10.1016/j.jpeds.2026.115003","url":null,"abstract":"<p><strong>Objective: </strong>To build a time-series machine learning (ML) model that improves bronchopulmonary dysplasia (BPD) prediction compared with published online calculators.</p><p><strong>Study design: </strong>We used a single-center, extremely low gestational age newborn cohort (inborn, birth year 2016-2021, n = 438). The primary outcome was a 5-level class outcome for BPD as defined by the Neonatal Research Network (NRN) in 2019. Flowsheet data were extracted from the electronic medical record. Time-series data were generated from birth onward, with 14 static and 35 dynamic input attributes. Iterative static (regression) and dynamic (ML) modeling was performed, comparing model performance with the NRN BPD calculator at several time points (postnatal day 1, 3, 7, 14, and 28) and ranking feature leverage at each time point.</p><p><strong>Results: </strong>Of the original cohort, 92 infants met all inclusion criteria (gestational age 25.6 ± 1.4 weeks). Static models performed comparably with the NRN BPD calculator (area under the curve = 0.7460), improving to 0.7978 with forward/backward selection. In contrast, dynamic long short-term memory (LSTM) models outperformed static models at all time points, reaching a peak area under the curve of 0.8400 on postnatal day 28. LSTM models performed best for no BPD and severe disease/death. Principal component analysis revealed that respiratory support, ventilator settings, supplemental oxygen requirements, medications, and prenatal/postnatal growth were major factors driving BPD severity.</p><p><strong>Conclusions: </strong>LSTM-based ML time-series analysis substantially outperformed static approaches for predicting BPD and death among extremely low gestational age newborns. Integrating ML methods into clinical applications holds promise for enhancing real-time BPD trajectory mapping.</p>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":" ","pages":"115003"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12833681/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1016/j.jpeds.2026.115005
Sanchi Malhotra MD , Keiko C. Salazar PhD , Neema Pithia MD , Ishminder Kaur MD , Kristina Adachi MD , Nanda Ramachandar MD , Austin L. Terwilliger PhD , Anthony Maresso PhD , Robert S. Venick MD , Suzanne V. McDiarmid MD , John S. Bradley MD
Antimicrobial resistance is life-threatening to pediatric patients with medical complexity who receive multiple courses of broad-spectrum antibiotics. Bacteriophages offer a safe treatment alternative when our antibiotic armamentarium is no longer sufficient. We describe successful use of bacteriophage therapy on a patient with a recalcitrant Pseudomonasaeruginosa infection after receiving a multiorgan transplant.
{"title":"Successful Bacteriophage Treatment of a Recalcitrant Intra-Abdominal Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa in a 2-Year-Old Child","authors":"Sanchi Malhotra MD , Keiko C. Salazar PhD , Neema Pithia MD , Ishminder Kaur MD , Kristina Adachi MD , Nanda Ramachandar MD , Austin L. Terwilliger PhD , Anthony Maresso PhD , Robert S. Venick MD , Suzanne V. McDiarmid MD , John S. Bradley MD","doi":"10.1016/j.jpeds.2026.115005","DOIUrl":"10.1016/j.jpeds.2026.115005","url":null,"abstract":"<div><div>Antimicrobial resistance is life-threatening to pediatric patients with medical complexity who receive multiple courses of broad-spectrum antibiotics. Bacteriophages offer a safe treatment alternative when our antibiotic armamentarium is no longer sufficient. We describe successful use of bacteriophage therapy on a patient with a recalcitrant <em>P</em><em>seudomonas</em> <em>aeruginosa</em> infection after receiving a multiorgan transplant.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"291 ","pages":"Article 115005"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-17DOI: 10.1016/j.jpeds.2026.114992
Abbot R. Laptook MD , Adam Czynski DO , Rouba Chahine PhD , Rachel G. Greenberg MD MB MHS , P. Brian Smith MD , Erica Oliveira BA , Jenna Gabrio MPH , Barry Eggleston MS , Abhik Das PhD , Jeannette Lee PhD , Barry Lester PhD , Dave Clark DrPH, MPH , Michele Walsh MD , Helen Ko MD , Clare Campbell Asher MD , Hayley Friedman MD , Samuel Gentle MD , Karishma Rao MD , Anup Katheria MD , Kristen Benninger MD , Jessica Snowden MD
Objective
To determine if newborns receiving morphine or methadone as the primary pharmacologic treatment for neonatal opioid withdrawal syndrome (NOWS) tolerate and receive fewer days of opioid using an accelerated wean protocol (15% decrements) compared with using a slower wean protocol (10% decrements).
Study design
Newborns ≥36 weeks of gestation receiving morphine or methadone for NOWS were enrolled in a pragmatic blinded, randomized multicenter trial. Newborns underwent protocol-driven weaning with decreasing opioid doses of either 15% or 10% decrements. Weaning was encouraged every 24 hours, and if signs of NOWS worsened, the preceding dose was resumed. To maintain blinding, the last 3 dose levels of the 15% decrements were placebo. The primary outcome was the number of days of opioid treatment from the first weaning dose to cessation of opioids.
Results
Slow enrollment prompted early trial closure; 189 newborns were randomized, 98 (51.9%) to 15% decrements (mean ± SD, 38.8 ± 1.2 weeks gestation, 59.8% male) and 91 (48.1%) to 10% decrements (38.8 ± 1.3 weeks gestation, 61.5% male). Morphine was used most commonly. Intention-to-treat analysis included all but 4 infants withdrawn in the 15% decrement group. The durations of opioid treatment during weaning were 8.2 (7.2, 9.5) (adjusted mean [95% CI]) and 11.2 (9.7, 12.9) days for 15% and 10% decrement groups, respectively (P < .001). Adverse events were few in both groups.
Conclusion
Pharmacologic treatment of NOWS using an accelerated wean protocol (15% decrements) was well tolerated with fewer days of opioid treatment compared with 10% decrements.
{"title":"Accelerated Weaning of Opioids to Reduce Pharmacologic Exposure for Neonatal Opioid Withdrawal Syndrome: A Randomized Clinical Trial","authors":"Abbot R. Laptook MD , Adam Czynski DO , Rouba Chahine PhD , Rachel G. Greenberg MD MB MHS , P. Brian Smith MD , Erica Oliveira BA , Jenna Gabrio MPH , Barry Eggleston MS , Abhik Das PhD , Jeannette Lee PhD , Barry Lester PhD , Dave Clark DrPH, MPH , Michele Walsh MD , Helen Ko MD , Clare Campbell Asher MD , Hayley Friedman MD , Samuel Gentle MD , Karishma Rao MD , Anup Katheria MD , Kristen Benninger MD , Jessica Snowden MD","doi":"10.1016/j.jpeds.2026.114992","DOIUrl":"10.1016/j.jpeds.2026.114992","url":null,"abstract":"<div><h3>Objective</h3><div>To determine if newborns receiving morphine or methadone as the primary pharmacologic treatment for neonatal opioid withdrawal syndrome (NOWS) tolerate and receive fewer days of opioid using an accelerated wean protocol (15% decrements) compared with using a slower wean protocol (10% decrements).</div></div><div><h3>Study design</h3><div>Newborns ≥36 weeks of gestation receiving morphine or methadone for NOWS were enrolled in a pragmatic blinded, randomized multicenter trial. Newborns underwent protocol-driven weaning with decreasing opioid doses of either 15% or 10% decrements. Weaning was encouraged every 24 hours, and if signs of NOWS worsened, the preceding dose was resumed. To maintain blinding, the last 3 dose levels of the 15% decrements were placebo. The primary outcome was the number of days of opioid treatment from the first weaning dose to cessation of opioids.</div></div><div><h3>Results</h3><div>Slow enrollment prompted early trial closure; 189 newborns were randomized, 98 (51.9%) to 15% decrements (mean ± SD, 38.8 ± 1.2 weeks gestation, 59.8% male) and 91 (48.1%) to 10% decrements (38.8 ± 1.3 weeks gestation, 61.5% male). Morphine was used most commonly. Intention-to-treat analysis included all but 4 infants withdrawn in the 15% decrement group. The durations of opioid treatment during weaning were 8.2 (7.2, 9.5) (adjusted mean [95% CI]) and 11.2 (9.7, 12.9) days for 15% and 10% decrement groups, respectively (<em>P</em> < .001). Adverse events were few in both groups.</div></div><div><h3>Conclusion</h3><div>Pharmacologic treatment of NOWS using an accelerated wean protocol (15% decrements) was well tolerated with fewer days of opioid treatment compared with 10% decrements.</div></div><div><h3>Trial registration</h3><div><span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> number: NCT04214834</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"292 ","pages":"Article 114992"},"PeriodicalIF":3.5,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-17DOI: 10.1016/j.jpeds.2026.114993
Colleen J. Djordjevich PharmD, BCPPS , Jacqueline Magers PharmD, BCPS , Joseph B. Cantey MD, MPH , Pavel Prusakov PharmD, BCPPS, BCIDP , Pablo J. Sánchez MD
Objective
To evaluate the effectiveness and safety of short (≤8 days) vs long (≥9 days) duration of antibiotic therapy for uncomplicated gram-negative (GN) bloodstream infections (BSI) among infants in the neonatal intensive care unit (NICU).
Study design
Retrospective analysis of infants treated for GN BSI at 7 NICUs within 2 health care systems. Infants were identified by review of positive blood cultures from the microbiology laboratory and electronic health records. Patients were excluded if they had polymicrobial BSI, meningitis/osteomyelitis/endocarditis, or died before completion of therapy as ordered. The primary outcome was recurrence of BSI with the same organism within 14 days of discontinuation of effective antimicrobial therapy (“treatment failure.”) Secondary outcomes were emergence of GN multidrug-resistant organisms (MDRO) and mortality.
Results
In all, 76 infants (39 short duration; 37 long duration) were included; 15 (38%) and 25 (69%) infants had a central venous catheter in place at onset of BSI in the short and long duration groups, respectively. Escherichia coli was the most common pathogen in both groups (27 [69%], short duration; 18 [49%], long duration). There were 2 recurrences of BSI, both in the long duration group. Among study infants, 5 had a subsequent GN MDRO infection; all were in the long duration group.
Conclusions
Treatment failure and GN MDROs occurred among infants who received ≥9 days of antibiotic therapy. Shorter antibiotic duration (≤8 days) appeared to be an effective intervention that could reduce antibiotic exposure and its adverse consequences among NICU infants.
{"title":"Duration of Antibiotic Therapy for Gram-Negative Bloodstream Infections in the Neonatal Intensive Care Unit","authors":"Colleen J. Djordjevich PharmD, BCPPS , Jacqueline Magers PharmD, BCPS , Joseph B. Cantey MD, MPH , Pavel Prusakov PharmD, BCPPS, BCIDP , Pablo J. Sánchez MD","doi":"10.1016/j.jpeds.2026.114993","DOIUrl":"10.1016/j.jpeds.2026.114993","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the effectiveness and safety of short (≤8 days) vs long (≥9 days) duration of antibiotic therapy for uncomplicated gram-negative (GN) bloodstream infections (BSI) among infants in the neonatal intensive care unit (NICU).</div></div><div><h3>Study design</h3><div>Retrospective analysis of infants treated for GN BSI at 7 NICUs within 2 health care systems. Infants were identified by review of positive blood cultures from the microbiology laboratory and electronic health records. Patients were excluded if they had polymicrobial BSI, meningitis/osteomyelitis/endocarditis, or died before completion of therapy as ordered. The primary outcome was recurrence of BSI with the same organism within 14 days of discontinuation of effective antimicrobial therapy (“treatment failure.”) Secondary outcomes were emergence of GN multidrug-resistant organisms (MDRO) and mortality.</div></div><div><h3>Results</h3><div>In all, 76 infants (39 short duration; 37 long duration) were included; 15 (38%) and 25 (69%) infants had a central venous catheter in place at onset of BSI in the short and long duration groups, respectively. <em>Escherichia coli</em> was the most common pathogen in both groups (27 [69%], short duration; 18 [49%], long duration). There were 2 recurrences of BSI, both in the long duration group. Among study infants, 5 had a subsequent GN MDRO infection; all were in the long duration group.</div></div><div><h3>Conclusions</h3><div>Treatment failure and GN MDROs occurred among infants who received ≥9 days of antibiotic therapy. Shorter antibiotic duration (≤8 days) appeared to be an effective intervention that could reduce antibiotic exposure and its adverse consequences among NICU infants.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"292 ","pages":"Article 114993"},"PeriodicalIF":3.5,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-17DOI: 10.1016/j.jpeds.2026.114994
Monique Moore Hill MA , Devon Gangi PhD , Shy Maqbool BS , Rachel Ni MS , Chandni Parikh PhD , Sally Ozonoff PhD
Objective
To evaluate repetitive motor behaviors (RMBs) in non-autistic toddlers using direct observational methods.
Study design
This cohort study assessed RMBs in a community sample of 679 toddlers at 24 and 36 months of age. Initial analyses examined rates of RMBs in autistic (n = 65) vs nonautistic (n = 614) participants. Subsequent analyses focused on participants without autism, first examining clinical correlates of RMBs in the full non-autistic group and then comparing rates of RMBs in 2 non-autistic subgroups: 104 participants with other developmental concerns (ODC) and 510 participants with no developmental concerns.
Results
A total of 36% of non-autistic children demonstrated RMB at 24 and/or 36 months of age. RMBs were significantly more likely in the ODC (55%) than the no developmental concerns (33%) group. Non-autistic participants with RMBs had significantly lower communication scores at 24 months and, at both ages, significantly higher scores on 2 measures of autism-related symptomatology than those without RMBs; however, group means fell within the average range and effect sizes were small. There were no RMB differences based on sex.
Conclusions
RMBs are not uncommon in 24- to 36-month-old children who do not meet diagnostic criteria for autism. Among non-autistic children, RMBs are most likely to occur in those with other developmental challenges but are also present in some typically developing children. The presence of RMBs in toddlers should be evaluated within the context of Diagnostic and Statistical Manual of Mental Disorders, fifth edition ASD criteria, and RMBs alone without social communication challenges core to ASD should not be viewed as automatically indicative of autism.
{"title":"Repetitive Motor Behaviors in Non-Autistic Toddlers","authors":"Monique Moore Hill MA , Devon Gangi PhD , Shy Maqbool BS , Rachel Ni MS , Chandni Parikh PhD , Sally Ozonoff PhD","doi":"10.1016/j.jpeds.2026.114994","DOIUrl":"10.1016/j.jpeds.2026.114994","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate repetitive motor behaviors (RMBs) in non-autistic toddlers using direct observational methods.</div></div><div><h3>Study design</h3><div>This cohort study assessed RMBs in a community sample of 679 toddlers at 24 and 36 months of age. Initial analyses examined rates of RMBs in autistic (n = 65) vs nonautistic (n = 614) participants. Subsequent analyses focused on participants without autism, first examining clinical correlates of RMBs in the full non-autistic group and then comparing rates of RMBs in 2 non-autistic subgroups: 104 participants with other developmental concerns (ODC) and 510 participants with no developmental concerns.</div></div><div><h3>Results</h3><div>A total of 36% of non-autistic children demonstrated RMB at 24 and/or 36 months of age. RMBs were significantly more likely in the ODC (55%) than the no developmental concerns (33%) group. Non-autistic participants with RMBs had significantly lower communication scores at 24 months and, at both ages, significantly higher scores on 2 measures of autism-related symptomatology than those without RMBs; however, group means fell within the average range and effect sizes were small. There were no RMB differences based on sex.</div></div><div><h3>Conclusions</h3><div>RMBs are not uncommon in 24- to 36-month-old children who do not meet diagnostic criteria for autism. Among non-autistic children, RMBs are most likely to occur in those with other developmental challenges but are also present in some typically developing children. The presence of RMBs in toddlers should be evaluated within the context of Diagnostic and Statistical Manual of Mental Disorders, fifth edition ASD criteria, and RMBs alone without social communication challenges core to ASD should not be viewed as automatically indicative of autism.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"292 ","pages":"Article 114994"},"PeriodicalIF":3.5,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1016/j.jpeds.2026.114991
Michael D Cabana, Samantha R Levano, Pedro A de Alarcon, Xylina D Bean, Loretta Cordova de Ortega, Laura Degnon, Phyllis A Dennery, Lewis R First, Kersten Hildebrandt-Abdikarim, Charles Schleien, Lilia Parra-Roide, Glenn Flores
{"title":"Impact of the Supreme Court and State Legislation on Pediatric Diversity Initiatives.","authors":"Michael D Cabana, Samantha R Levano, Pedro A de Alarcon, Xylina D Bean, Loretta Cordova de Ortega, Laura Degnon, Phyllis A Dennery, Lewis R First, Kersten Hildebrandt-Abdikarim, Charles Schleien, Lilia Parra-Roide, Glenn Flores","doi":"10.1016/j.jpeds.2026.114991","DOIUrl":"10.1016/j.jpeds.2026.114991","url":null,"abstract":"","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":" ","pages":"114991"},"PeriodicalIF":3.5,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}